Your browser doesn't support javascript.
loading
Telemonitoring of the Continuum of Care of Hepatitis C During the COVID-19 Pandemic in Brazil.
Bittencourt, Paulo Lisboa; Codes, Liana; César, Alessandra Maria Dias Guimarães; Mussi, Fernanda Carneiro; Ferraz, Maria Lúcia Gomes.
Affiliation
  • Bittencourt PL; Brazilian Liver Institute, São Paulo, Brazil.
  • Codes L; Bahiana School of Medicine and Public Health, Bahia, Brazil.
  • César AMDG; Portuguese Hospital, Bahia, Brazil.
  • Mussi FC; Brazilian Liver Institute, São Paulo, Brazil.
  • Ferraz MLG; Bahiana School of Medicine and Public Health, Bahia, Brazil.
Telemed J E Health ; 29(11): 1673-1678, 2023 11.
Article in En | MEDLINE | ID: mdl-36888957
ABSTRACT

Introduction:

To accomplish elimination of hepatitis C virus (HCV) by 2030, as proposed by the World Health Organization, the Brazilian Ministry of Health outlined the Hepatitis C Elimination Plan, which provides coverage of all critical steps in the continuum of care (CoC) of hepatitis C. As expected, the advent of COVID-19 pandemic has disrupted the CoC of hepatitis C worldwide. The Brazilian Liver Institute launched a remote patient monitoring (RPM) program to assist the general population at risk in HCV testing and to provide linkage and retention to care for HCV-positive subjects. The RPM program was also designed to relink HCV-positive patients lost to follow-up during the COVID-19 pandemic due to their limited access to the health care system.

Methods:

The HCV telemonitoring number was highly advertised in Brazilian media. The RPM program was conducted by dedicated health care personnel trained to follow a predefined script designed to provide awareness, ensure consistent information for educational purposes, and recruit eligible participants to be tested for HCV.

Results:

From August 2020 to December 2021, 3,738 subjects entered in contact with RPM. There were 26,884 interactions (mean 7.2 interactions per participant), mostly by WhatsApp (78%). Twenty out of those 221 subjects (9%) who tested were HCV positive. Those subjects altogether with 128 other patients with HCV, tested elsewhere, were followed in the HCV CoC. Up to now, 94% of them were linked to care, 24% are undergoing treatment and 8% achieved sustained virological response (SVR).

Conclusions:

Our preliminary results showed that HCV CoC telemonitoring was a feasible and useful strategy to follow HCV at-risk subjects through all cascade of care until SVR during the COVID-19 health care disruption. It could be used beyond the defervescence of SARS-CoV-2 pandemic to ensure linkage to care of those HCV-positive patients.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hepatitis C / COVID-19 Limits: Humans Country/Region as subject: America do sul / Brasil Language: En Journal: Telemed J E Health Journal subject: INFORMATICA MEDICA / SERVICOS DE SAUDE Year: 2023 Document type: Article Affiliation country: Brazil

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hepatitis C / COVID-19 Limits: Humans Country/Region as subject: America do sul / Brasil Language: En Journal: Telemed J E Health Journal subject: INFORMATICA MEDICA / SERVICOS DE SAUDE Year: 2023 Document type: Article Affiliation country: Brazil